1. Cabergoline in the treatment of acromegaly: a study in 64 patients;Abs;J Clin Endocrinol Metab,1998
2. Affssaps. Prise en charge thérapeutique du patient dyslipidémique in Recommandations de Bonne Pratique, Agence Française de Sécurité Sanitaire des Produits de Santé, Affssaps 2005 ; 1-65.
3. Explicit criteria for determining potentially inappropriate medication use by the elderly;Beers;Arch Intern Med,1997
4. Population Projections of the U.S. by Age, Sex, Race, and Hispanic Origin: 1993 to 2020 in Current Population Reports. U. G. P. Office. Washington;Campbell;DC:,1994
5. Cardiovascular effects of the somatostatin analog octreotide in acromegaly;Chanson;Ann Intern Med,1990